← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 31, 2007Last known activity
Mar 20, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (15 distinct, 11 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Recent trials (11)
- NCT05430620Overall official - principal investigatorPhase 3Mar 20, 2022
- NCT04812704Overall official - principal investigatorN/AMar 9, 2021
- NCT04500236Overall official - principal investigatorN/ASep 1, 2020
- NCT03864575Overall official - principal investigatorPhase 2Apr 15, 2019
- NCT03966196Overall official - principal investigatorN/AFeb 11, 2019
- NCT03476109Overall official - principal investigatorPhase 4Mar 30, 2018
- NCT03388541Overall official - principal investigatorPhase 4Jan 17, 2018
- NCT03604471Overall official - principal investigatorPhase 4Aug 8, 2017
- NCT03356860Overall official - principal investigatorPhase 1/Phase 2Apr 13, 2017
- NCT04140409Overall official - principal investigatorPhase 4Feb 2, 2016
- NCT00634777Sponsor investigatorN/AJan 31, 2007
Details
- Last known activity
- Mar 20, 2022